Regulatory Releases
Amphion Innovations and Partner Companies
December 30, 2019
Cancellation of Trading on AIM
November 20, 2019
Directors' Dealings and Business Update
October 18, 2019
Settlement of Loan Facility
October 11, 2019
Sale of Partner Company Shares
October 3, 2019
Sale of Partner Company Shares
September 25, 2019
Amended Terms on Loan Facility: Maturity Date Extension
September 10, 2019
Sale of Partner Company Shares
August 9, 2019
Directorate Change
August 9, 2019
Sale of Partner Company Shares
June 27, 2019
Update 2018 Annual report and accounts
June 11, 2019
Update on Loan Facility
April 1, 2019
Update on Loan Facility
March 19, 2019
Sale of Partner Company Shares
March 15, 2019
Sale of Partner Company Shares
March 11, 2019
Amended Terms on Loan Facility
February 26, 2019
Convertible Promissory Note Extended to December 2019
February 14, 2019
Statement re. Motif Bio plc
February 7, 2019
Statement Regarding Price Movement
February 1, 2019
Appointment of Joint Broker
January 21, 2019
Amphion Partner Company, WellGen, Finalises License Agreement
2018
Archive 
December 11, 2018
Further investment in Polarean Imaging plc and Repayment of Loan Facility
October 16, 2018
Extended Repayment and Additional Draw Down on Loan Facility
September 28, 2018
Interim Financial Statements 2018
812K PDF
September 5, 2018
Board Change
August 21, 2018
Sale of Partner Company Shares
August 1, 2018
Results of AGM
June 29, 2018
Appointment of a New Director
June 26, 2018
Final Results for the Year Ended 31 December 2017
1260K PDF
May 23, 2018
Sale of Partner Company Shares
April 20, 2018
Directorate Change
March 29, 2018
Update on Polarean Imaging IPO
March 26, 2018
Update on Polarean Imaging proposed AIM IPO
March 2, 2018
Convertible Promissory Note Extended to December 2018
January 10, 2018
Directors' Dealing
2017
Archive
December 22, 2017
Amphion Partner Company, Polarean Imaging Limited, Closes Interim Funding
December 22, 2017
Extended Repayment and Additional Draw Down on Loan Facility
December 5, 2017
Share Issuance
November 23, 2017
Further Update on Polarean Imaging Limited
November 2, 2017
Order Dismissing DataTern Case
October 11, 2017
Related Party Transaction
October 5, 2017
Amphion Partner Company, Motif Bio, Announces Positive Topline Results for iclaprim in the REVIVE-2 Phase 3 Study
September 29, 2017
Interim Financial Statements 2017
706K PDF
September 25, 2017
Sale of Partner Company Shares
August 30, 2017
Sale of Partner Company Shares
August 1, 2017
Results of AGM
June 28, 2017
Amphion Innovations plc
Preliminary Results for the year ended 31 December 2016
1251K PDF
May 31, 2017
Partner Company m2m Imaging Merger Update
May 22, 2017
Additional Draw Down on Loan Facility
February 7, 2017
Additional Draw Down on Loan Facility
2016
Archive
December 16, 2016
Directors' Dealings
December 9, 2016
Directors' Dealings
September 8, 2016
Re-negotiated Terms of Motif Convertible Promissory Note
September 7, 2016
Interim Financial Statements 2016
797k PDF
August 22, 2016
Additional Draw Down on Loan Facility
July 29, 2016
Results of AGM and Directorship Change
July 18, 2016
Transfer of Shares
July 13, 2016
Notice of Intention to List on NASDAQ by Motif Bio plc
July 13, 2016
Additional Draw Down on Loan Facility
June 23, 2016
Amphion Innovations plc
Preliminary Results for the year ended 31 December 2015
1.24MB PDF
April 29, 2016
Additional Terms on Loan Facility
April 28, 2016
Additional Draw Down on Loan Facility
April 7, 2016
Amphion Settles Contested Arbitration Ruling
March 2, 2016
Convertible Promissory Note Extended to December 2017
January 7, 2016
Directors' Dealings
Directors Receive Shares in Lieu of Fees
January 5, 2016
Convertible Promissory Note and Macaleer Promissory Note Terms Extended
2015
Archive
November 26, 2015
Additional Draw on Loan Facility
November 5, 2015
Partner Company m2m Imaging Corp to Merge
October 30, 2015
Death of a Director
September 16, 2015
Directors' Dealings
Directors Receive Shares in Lieu of Fees
September 10, 2015
Subsidiary Company DataTern Receives Favourable Ruling
September 3, 2015
Interim Financial Statements 2015
817k PDF
August 7, 2015
Results of AGM
June 23, 2015
Motif Bio plc Announces Placing to Raise £22 million
June 23, 2015
Amphion Innovations plc
Preliminary Results for the year ended 31 December 2014
277k PDF
June 5, 2015
Placing to Raise £1.54 million
May 19, 2015
Appointment of Broker
April 15, 2015
Motif Bio plc Gains FDA Agreement to Enter Phase 3 Clinical Development with Iclaprim
April 7, 2015
Shares Issued for Exercised Warrants
April 2, 2015
First Day of Dealings on AIM for Amphion Partner Company, Motif Bio plc
March 24, 2015
Issue of Shares
March 20, 2015
Motif Bio Limited Update Re: Intention to Float
February 26, 2015
Issue of Shares
February 9, 2015
Directors' Dealings
Directors Receive Shares in Lieu of Fees
February 2, 2015
Notice of Intention to Float on AIM by Motif Bio Limited
January 22, 2015
Transfer of Shares
January 19, 2015
Motif BioSciences Acquires Late Stage Antibiotic and Announces pre-IPO Financing
January 5, 2015
Subsidiary Company DataTern Receives Favourable Appeal Ruling
2014
Archive
September 24, 2014
Directors' Dealings
Directors Receive Shares in Lieu of Fees
September 19, 2014
Interim Financial Statements 2014
90.2k PDF
September 9, 2014
Additional Draws on Loan Facility
August 28, 2014
Directorate Change
August 7, 2014
Annual General Meeting and Extraordinary General Meeting Results
July 10, 2014
Directors' Dealings
Directors Receive Shares in Lieu of Fees
June 20, 2014
Amphion Proposes Re-registration Under the IOM Companies Act 2006 (as amended)
June 18, 2014
Amphion Innovations plc
Preliminary Results for the year to 31 December 2013
266k PDF
June 5, 2014
Amphion Secures New Loan Facility
April 14, 2014
DataTern Receives Favourable Appeal Ruling
January 28, 2014
Convertible Promissory Note Extended Through December 2015
2013
Archive
December 12, 2013
Update on Convertible Promissory Note
November 13, 2013
Directors’ Dealings
Directors Receive Shares in Lieu of Fees
October 16, 2013
Amphion Innovations plc
Partner Company, Kromek, Announces First Day of Dealings on AIM
September 24, 2013
Amphion Innovations plc
Interim Financial Statements 2013
79.7k PDF
September 12, 2013
Amphion Innovations plc
Amphion Partner Company, Kromek, announces intention to float on AIM of the London Stock Exchange
August 13, 2013
Amphion Innovations plc
Annual General Meeting Results
June 1, 2013
Amphion Innovations plc
Directors Shareholding
June 28, 2013
Amphion Innovations plc
Preliminary Results for the year to 31 December 2012
248k PDF
April 18, 2013
Amphion Innovations plc
Directors Shareholding
April 17, 2013
Amphion Innovations plc
Trading Update
March 28, 2013
Amphion Innovations plc
Change of Adviser
2012 Archive
December 13, 2012
Amphion Innovations plc
Fundraising
October 3, 2012
Directors’ Dealings
Directors Receive Shares in Lieu of Fees
September 28, 2012
Amphion Innovations plc
Directors Shareholding
September 19, 2012
Amphion Innovations plc
Interim Financial Statements 2012
74k PDF
August 29, 2012
Amphion Innovations plc
Update: Patent Litigation
July 27, 2012
Amphion Innovations plc
Annual General Meeting Results
July 23, 2012
Directors’ Dealings
Directors Receive Shares in Lieu of Fees
July 20, 2012
Amphion Innovations plc
New Debt Facility
July 20, 2012
Amphion Innovations plc
Trading Update
June 11, 2012
Amphion Innovations plc
Preliminary Results for the year to 31 December 2011
202k PDF
May 9, 2012
Amphion Innovations plc
New Debt Facility
March 28, 2012
Amphion Partner Company Secures Credit Agreement
Axcess International Inc. (AXSI.PK), a provider of intelligent Wireless IDs, has entered into a credit agreement with RFID, LLC.
February 28, 2012
Directors’ Dealings
Directors Receive Shares in Lieu of Fees
February 23, 2012
Amphion Innovations plc
New Debt Facility
February 3, 2012
Amphion Innovations plc
New Debt Facility
February 2, 2012
Second DataTern Patent Approved
2011 Archive
December 30, 2011
Directors’ Dealings
Directors Shareholding
December 6, 2011
Directors’ Dealings
Directors Receive Shares in Lieu of Fees
November 21, 2011
Amphion Subsidiary Files Additional Patent Infringement Suits
For Its Object-Oriented Software/ Relational Database Patent New Debt Facility
September 29, 2011
Amphion Innovations plc
Interim Financial Statements 2011
215k PDF
September 9, 2011
Amphion Innovations plc
Issue of Equity
August 2, 2011
Amphion Innovations plc
Trading Update
July 27, 2011
Amphion Innovations plc
Adjournment of AGM
July 22, 2011
Amphion Innovations plc
Directors’ Dealings
Directors Receive Shares in Lieu of Fees
July 21, 2011
Amphion Innovations plc
Directors Shareholding
June 30, 2011
Amphion Innovations plc
Preliminary Results for the year to 31 December 2010
513k PDF
June 21, 2011
Amphion Innovations plc
New Debt Facility
April 15, 2011
Amphion Innovations plc
New Debt Facility
April 14, 2011
Amphion Innovations plc
Notice of Preliminary Results
April 13, 2011
Amphion Innovations plc
Update on U.S. Subsidiary, DataTern, Inc., Patent Litigation
March 30, 2011
Amphion Innovations plc
IP Developments and New Chairman
February 28, 2011
Amphion Innovations plc
Full Year Trading Update
January 6, 2011
Amphion Innovations plc
Change of Adviser
January 5, 2011
Amphion Innovations plc
IP License Agreements
2010 Archive
December 9, 2010
Amphion Innovations plc New
Debt Facility
October 18, 2010
Directors Dealings
September 24, 2010
Amphion Innovations plc
IP Licensing
September 10, 2010
Interim Financial Statements 2010
500k PDF
June 8, 2010
Amphion Innovations plc
AGM Statement
May 18, 2010
Directors’ Dealings
Directors Receive Shares in Lieu of Fees
March 16, 2010
Amphion Innovations plc Preliminary Results for the year to 31 December 2009
189k PDF
March 15, 2010
Amphion Partner Company, Kromek,
Completes £12.3 Million Fund Raising
February 2, 2010
Amphion Innovations plc Full Year Trading Update
January 6, 2010
Directors’ Dealings
Directors Receive Shares in Lieu of Fees
2009 Archive
December 23, 2009
Amphion Innovations plc Funding Update and Signs Eight License Agreements worth $4.15 million
October 16, 2009
Directors' Dealings
Directors Receive Shares in Lieu of Fees
September 21, 2009
Directors' Dealings
Directors Receive Shares in Lieu of Fees
August 20, 2009
Amphion Interim Results 2009 415k PDF
June 25, 2009
Amphion Innovations plc Partner Company, DataTern, Signs Four License Agreements worth $1.8 million
June 4, 2009
Amphion Innovations plc AGM Statement
May 5, 2009
Amphion Innovations plc Partner Company, DataTern,
Signs Three IP License Agreements worth $1.65m
May 1, 2009
Amphion Innovations plc
Directorate Change
April 7, 2009
Directors' Dealings
Directors Receive Shares in Lieu of Fees
March 26, 2009
Directors' Dealings
March 16, 2009
Amphion Innovations plc
Preliminary Results
for the year to 31 December 2008
204k PDF
March 4, 2009
Amphion Innovations plc Notice of Prelim Results
Amphion Innovations plc (LSE: AMP), which builds shareholder value in high growth companies in the medical and technology sectors, will announce its Prelim results for the year ending 31 December 2008 on Monday 16 March 2009.
February 27, 2009
Amphion Innovations Director Dealings
Distribution to Board Members
February 27, 2009
Amphion Innovations plc Partner Company, AXCESS International,
Wins $3.5 million Port Infrastructure Award
January 30, 2009
Amphion Innovations plc Funding Update
January 19, 2009
Amphion Innovations plc Full Year Trading Update
2008 Archive
December 31, 2008
Amphion Innovations plc Raises £1,857,900
November 27, 2008
Amphion Innovations plc Partner Company, DataTern, Signs
Third IP License Agreement
October 23, 2008
Amphion Innovations plc Director/PDMR Shareholding
October 17, 2008
Amphion Innovations plc Partner Company DataTern Signs IP License Agreement with VISA
September 16, 2008
Amphion Innovations plc Directors Dealings
Board Members receive shares in lieu of fees
August 18, 2008
Amphion Innovations plc Interim Results
Interims Results for the 6 months to 30 June 2007, 35.7% increase in Net Asset Value per Share Strong Partner Company progress
June 12, 2008
Amphion Innovations plc AGM Statement
June 10, 2008
Amphion Innovations plc Partner Company DataTern
Announces Agreement of First IP License
May 27, 2008
Amphion Innovations plc Partner Company Durham Scientific Crystals, Ltd. Closes £1.6 million Fundraising
April 8, 2008
Amphion’s Partner Company, Myconostica Ltd.,
Closes Further £3.9 Million Round Financing
April 7, 2008
Amphion Innovations plc
Fundraising and Directors Dealings
March 26, 2008
Amphion Innovations plc Director Shareholdings
Richard Morgan, CEO, Purchases Shares
March 13, 2008
Amphion Innovations plc Preliminary Results
Increase in Net Asset Value per share reflects continued growth of Partner Companies
225k PDF
March 3, 2008
Amphion’s New Partner Company, PrivateMarkets Inc.
Completes $3.75 million Series A Financing
February 27, 2008
Amphion Innovations plc
Notice of Preliminary Results – 13 March 2008
January 17, 2008
Amphion Innovations plc
Trading Update
January 7, 2008
Amphion Partner Company, Directors Dealings
Board members receive shares in lieu of fees
2007 Archive
December 03, 2007
Amphion Partner Company, Durham Scientific Crystals, signs
Airport Security Deal
World-leading technology to revolutionise airport security
Technology to reduce terrorist threat and speed up check-in process
November 12, 2007
Amphion Innovations plc
Subscription of 2,272,728 New Ordinary Shares
November 05, 2007
Amphion Innovations plc Result of EGM
October 29, 2007
Amphion Partner Company, WellGen Inc., Completes $9.5 million Series C Financing
October 12, 2007
Amphion Innovations plc
Proposed Issue of 15,909,077 New Ordinary Shares and Notice of Extraordinary General Meeting
September 12, 2007
Amphion Innovations plc
Interim Results show 35.7% increase in Net Asset Value per Share and Strong Partner Company Progress
August 28, 2007
Interims to be Released on 12 September 2007
August 22, 2007
Amphion Innovations plc Change of Adviser
August 16, 2007
Amphion Innovations plc Website
August 14, 2007
Amphion Innovations plc Partner Company Durham Scientific Crystals Ltd. Closes £3.5 million Fundraising
July 30, 2007
Amphion Innovations Partner Company Myconostica Limited Closes £570,000 Round Financing
July 2, 2007
Amphion Innovations plc £2.1m Placing
June 7, 2007
Amphion Innovations plc AGM Statement
April 30, 2007
Amphion Innovations plc Director Shareholdings - Richard Morgan, CEO Purchases Shares
April 5, 2007
Amphion Innovations Partner Company Motif BioSciences Closes $1m Financing
March 23, 2007
Port of Barbados Selects Axcess to Provide Security Systems for the Cricket World Cup 2007
March 15, 2007
Amphion Innovations plc Preliminary Results
33% Increase In Net Asset Value Per Share Reflects Strong Progress with Partner Companies.
174k PDF
February 26, 2007
Amphion Innovations plc, the developer of technology and life sciences businesses will report its preliminary results for the year ending 31 December 2006 on Thursday 15 March 2007
February 9, 2007
Amphion Innovations Partner Company Durham Scientific Crystals Closes £1.6m Round Financing
January 16, 2007
Amphion Innovations, plc Trading Update
January 16, 2007
Amphion Innovations, plc Creation of a Gulf-based Joint Venture
January 5, 2007
Amphion Innovations, plc Fundraising
2006 Archive
November 20, 2006
Amphion Innovations plc Acquires 35% Stake In University of Manchester Molecular Diagnostic Spin-Out Company
November 13, 2006
Amphion Innovations plc Partner Company Supertron Acquires Spin Systems
November 7, 2006
Amphion Innovations Partner Company Durham Scientific Crystals Closes £875,000 Financing
September 14, 2006
Amphion Innovations plc Partner Company WellGen Appoints Dr Kathleen Mullinix as New CEO
September 12, 2006
Amphion Innovations plc Change of NOMAD and Broker
September 07, 2006
Amphion Innovations plc Interim Results Show 21 Percent Gain in Fair Value of Investments
August 22, 2006
FireStar Software, Inc. Raises Additional $2 Million
August 09, 2006
Amphion Innovations Placing Raising £1,032,800
July 24, 2006
Amphion Innovations Partner Company Supertron Raises $3.5 Million In Series C Financing
June 8, 2006
Amphion Innovations Names Zaki Hosny of Merck and Company CEO of Partner Company Motif BioSciences
June 8, 2006
Amphion Innovations plc Annual General Meeting — Trading Update
June 6, 2006
Amphion Innovations plc Signs Memorandum of Understanding with University of Manchester Spinout Myconostica Ltd.
June 1, 2006
Posting of Annual Report and Accounts
Amphion has posted its 2005 Annual Report and Accounts. Copies of these accounts and the notice convening the AGM have been sent to shareholders by post and are available at the Company's website at http://www.amphionplc.com. The 2006 Annual General Meeting will be held on 8 June 2006 at noon at the offices of Financial Dynamics, Holborn Gate, 26 Southampton Buildings, London WC2A 1PB.
March 15, 2006
Amphion Innovations plc Partner Company AXCESS International Completes $2.3M Funding
March 8, 2006
2006 Preliminary Results
Preliminary Results Show 24% Increase In Net Asset Value Per Share Over Four Months Since IPO
169k PDF
February 16, 2006
WellGen, Inc., Leading Nutrigenomics Company, Completes $3M Series B Financing
January 3, 2006
Additional Investment in Portfolio Companies
2005 Archive
December 5, 2005
Amphion Innovations Announces Further Investment
November 8, 2005
WellGen Taps Arthur H. Finnel, Food and Biotech Industry Veteran, To Be New Chief Financial Officer
October 10, 2005
Amphion Innovations Acquires a 30% stake in Medical Imaging Company
September 21, 2005
Amphion Innovations acquires 29% stake in award winning Durham University spin-out company
August 30, 2005
Amphion Innovations Invests Additional $1M in Leading Nutrigenomics Company, WellGen, Inc.
August 23, 2005
Amphion Innovations - Admission to trading on AIM
Amphion Innovations PLC (“Amphion”), a developer of life sciences companies, announces that trading in the Company’s shares will commence today on the AIM market of the London Stock Exchange at 08.00 under the ticker symbol AMP.
20k PDF
August 22, 2005
Amphion Innovations Completes IPO
August 16, 2005
Intention to Float